Tevis Investment Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$242K Hold
1,546
0.13% 95
2026
Q1
$236K Buy
+1,546
New +$237K 0.13% 94
2022
Q4
Sell
-1,391
Closed -$105K 157
2022
Q3
$105K Hold
1,391
0.1% 127
2022
Q2
$117K Hold
1,391
0.11% 116
2022
Q1
$122K Hold
1,391
0.11% 127
2021
Q4
$122K Buy
+1,391
New +$115K 0.11% 135

Other funds holding NVS

Tevis Investment Management's NVS Position: Q2 2026 in Review

Tevis Investment Management held its Novartis (NVS) position steady in Q2 2026 at 1,546 shares worth $242K. The position accounts for 0.13% of the portfolio, ranked #95.

Tevis Investment Management first reported a position in NVS in Q4 2021 and has held it in 6 quarters since. 1,614 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Tevis Investment Management held 1,546 shares of Novartis worth $242K as of Q2 2026.
  • Tevis Investment Management left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.13% of Tevis Investment Management's portfolio in Q2 2026, its #95 holding.
  • Tevis Investment Management first reported a position in Novartis in Q4 2021 and has held it in 6 quarters since.
  • 1,614 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Tevis Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.